Miromatrix Medical Inc. (MIRO)
3.39
0.02 (0.59%)
At close: Dec 12, 2023, 9:00 PM
Company Description
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs.
Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells.
The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute.
The company was formerly known as TayTech, Inc.
Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
Miromatrix Medical Inc.
| Country | United States |
| IPO Date | Jun 24, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 76 |
| CEO | Dr. Jeffrey James Ross Ph.D. |
Contact Details
Address: 6455 Flying Cloud Drive Eden Prairie, Minnesota United States | |
| Website | https://www.miromatrix.com |
Stock Details
| Ticker Symbol | MIRO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001527096 |
| CUSIP Number | 60471P108 |
| ISIN Number | US60471P1084 |
| Employer ID | 27-1285782 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jeffrey James Ross Ph.D. | Chief Executive Officer & Director |
| Brian D. Niebur CPA | Chief Financial Officer & Vice President of Fin. |
| James M. Douglas | Chief Financial Officer & Secretary |
| Dr. John Joseph Barry Ph.D. | Vice President of R&D |
| Rodrigo Mesquita P.M.P. | Vice President of Manufacturing & Operations |
| Tom Emig | Vice President of People & Culture |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Dec 26, 2023 | 15-12G | Filing |
| Dec 22, 2023 | SC 13D | Filing |
| Dec 18, 2023 | 8-K | Current Report |
| Dec 14, 2023 | 3 | Filing |
| Dec 13, 2023 | 4 | Filing |
| Dec 13, 2023 | 4 | Filing |
| Dec 13, 2023 | 4 | Filing |
| Dec 13, 2023 | 4 | Filing |